Events on 22 April 2024

Quality control in serology laboratory presentation

Quality control in serology laboratory presentation, given at the IBMS London Branch Virology Discussion Group on 4th June 2019

Point of Care Testing Biopod Vol 1

The IBMS Biopod is a monthly podcast for members. Each episode will feature experts from the field discussing their research and talking about the latest developments.

EUROIMMUN Symposium: Advancing Laboratory Excellence

Allocated as Lecture/Study: 2h 15m
Allocated as Practical Element: 1h 00m
Allocated as Q&A/Discussion: 1h 15m

Transitioning to ISO 15189: Support Hubs 2024

Debra Padgett, Past President of the IBMS, is hosting a new Support Hub series to support our members with the transition to the ISO 15189 standard.

IBMS Support Hubs 2024

We have organised a collection of engaging and informative sessions, that will run from March to December 2024, covering topics including neurodiversity in the workplace, inter-professional learning, returning to practice, and leadership in pathology.

Rapid On-Site Evaluation of Respiratory Cytology

ROSE is an expanding field particularly in head and neck, EBUS and EUS. The benefits of ROSE are well documented and multiple guidelines for best practice promote ROSE. Appropriate planning of services and training of staff is essential for any service to run safely and effectively. This course will aim to help staff providing the service to understand its many. These training days are suitable for those preparing for the IBMS ROSE qualification but are equally suited to those who just want to learn more about the service they are helping to provide. The course covers core medical, technical, and morphological aspects of head and neck, EBUS and EUS ROSE.
We have organised these days so that participants can attend the whole course or just selected days.

Course Aims.
At the end of the course the participants should:
• Understand the sample collection and preparation methods for these samples.
• Understand pre and post analytical variables. • Assess adequacy.
• Be able to recognise basic cell types.
• Be able to distinguish between clearly benign cells and those requiring further assessment.
• Understand the ancillary techniques that can be used in each case.
• Understand the equipment requirements.
• Understand the health & safety and information governance requirements.